Drug Type CAR-T |
Synonyms- |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators), CD20 modulators(B-lymphocyte antigen CD20 modulators), CD22 modulators(CD22 modulators) + [1] |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
B-Cell Lymphoma | Phase 2 | CN | 01 Jun 2017 | |
Carney Complex | Phase 2 | CN | 01 Jun 2017 | |
Non-Hodgkin's lymphoma refractory | Phase 2 | CN | 01 Jun 2017 | |
Recurrent Non-Hodgkin Lymphoma | Phase 2 | CN | 01 Jun 2017 |